FactSet Research Systems: Growth Inflected As Expected, Reiterate Strong Buy

FactSet Research Systems' 3Q25 results confirmed an anticipated growth inflection, marked by reaccelerating organic ASV and robust performance across diversified segments. The company is now materially monetizing AI through GenAI products, enhancing client integration and revenue. Despite near-term margin pressure from technology investments, the analyst maintains a Strong Buy rating and a $520 price target, asserting the stock is undervalued at 24x NTM P/E given its improving outlook and durable reacceleration thesis.

Analysis

FactSet's third-quarter 2025 results confirm a positive inflection in its growth trajectory, driven by a reacceleration in organic Annual Subscription Value (ASV) and resilient performance across diversified business segments. A critical development is the material monetization of its artificial intelligence initiatives, with new GenAI products now contributing directly to revenue and deepening the company's integration into client workflows. This increased client stickiness supports a thesis for durable growth reacceleration. Despite this top-line momentum, the company anticipates near-term margin pressure resulting from continued investments in technology. The analyst's valuation assessment, citing a 24x next-twelve-months P/E multiple, posits that the stock remains undervalued relative to its improving fundamental outlook and the $520 price target.

Key Decisions for Investors

• Investors may consider the current valuation at 24x NTM P/E an attractive entry point, given the evidence of reaccelerating organic growth and the emerging revenue stream from GenAI products.
• It is crucial to monitor the company's ability to sustain organic ASV growth in subsequent quarters to validate the durable reacceleration thesis.
• Traders should weigh the positive growth catalysts against the stated near-term margin pressure from technology investments, as this could impact profitability in the short term.